These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8957838)

  • 1. Evaluation of contamination of the dentist and dental surgery environment with Burkholderia (Pseudomonas) cepacia during treatment of children with cystic fibrosis.
    Pankhurst CL; Harrison VE; Philpott-Howard J
    Int J Paediatr Dent; 1995 Dec; 5(4):243-7. PubMed ID: 8957838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The environmental risk factors associated with medical and dental equipment in the transmission of Burkholderia (Pseudomonas) cepacia in cystic fibrosis patients.
    Pankhurst CL; Philpott-Howard J
    J Hosp Infect; 1996 Apr; 32(4):249-55. PubMed ID: 8744509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Burkholderia (Pseudomonas) cepacia disseminated from cystic fibrosis patients during physiotherapy?
    Ensor E; Humphreys H; Peckham D; Webster C; Knox AJ
    J Hosp Infect; 1996 Jan; 32(1):9-15. PubMed ID: 8904368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
    Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S
    Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
    Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of Burkholderia cepacia in the hospital environment.
    Moore JE; McIlhatton B; Buchanan J; Gilpin D; Shaw A; Hall V; Murphy PG; Elborn JS
    Ir J Med Sci; 2002; 171(3):131-3. PubMed ID: 15736349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of Burkholderia cepacia on environmental surfaces.
    Drabick JA; Gracely EJ; Heidecker GJ; LiPuma JJ
    J Hosp Infect; 1996 Apr; 32(4):267-76. PubMed ID: 8744511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study.
    Cazzola G; Amalfitano G; Tonolli E; Perazzoli C; Piacentini I; Mastella G
    Acta Paediatr; 1996 May; 85(5):554-7. PubMed ID: 8827098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Pseudomonas cepacia colonization among patients with cystic fibrosis.
    John M; Ecclestone E; Hunter E; Couroux P; Hussain Z
    Pediatr Pulmonol; 1994 Aug; 18(2):108-13. PubMed ID: 7526323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Airborne dissemination of Burkholderia (Pseudomonas) cepacia from adult patients with cystic fibrosis.
    Humphreys H; Peckham D; Patel P; Knox A
    Thorax; 1994 Nov; 49(11):1157-9. PubMed ID: 7530384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
    Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK
    J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak.
    Whiteford ML; Wilkinson JD; McColl JH; Conlon FM; Michie JR; Evans TJ; Paton JY
    Thorax; 1995 Nov; 50(11):1194-8. PubMed ID: 8553277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Burkholderia cepacia lower respiratory tract infection associated with exposure to a respiratory therapist.
    Ramsey AH; Skonieczny P; Coolidge DT; Kurzynski TA; Proctor ME; Davis JP
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):423-6. PubMed ID: 11583210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission and prevalence of Burkholderia cepacia in Welsh cystic fibrosis patients.
    Millar-Jones L; Ryley HC; Paull A; Goodchild MC
    Respir Med; 1998 Feb; 92(2):178-83. PubMed ID: 9616509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Pseudomonas (Burkholderia) cepacia using PCR.
    Campbell PW; Phillips JA; Heidecker GJ; Krishnamani MR; Zahorchak R; Stull TL
    Pediatr Pulmonol; 1995 Jul; 20(1):44-9. PubMed ID: 7478781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental sampling to detect Burkholderia cepacia in a cystic fibrosis outpatient clinic.
    Humphreys H; Peckhman D
    Eur J Clin Microbiol Infect Dis; 1996 Jun; 15(6):523-5. PubMed ID: 8839652
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary evolution of cystic fibrosis patients colonized by Pseudomonas aeruginosa and/or Burkholderia cepacia.
    Jacques I; Derelle J; Weber M; Vidailhet M
    Eur J Pediatr; 1998 May; 157(5):427-31. PubMed ID: 9625343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis.
    Walsh NM; Casano AA; Manangan LP; Sinkowitz-Cochran RL; Jarvis WR
    J Pediatr; 2002 Oct; 141(4):512-7. PubMed ID: 12378190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field inversion gel electrophoresis on Pseudomonas cepacia strains isolated from cystic fibrosis patients.
    Amalfitano G; Tonolli E; Favari F; Perazzoli C; Cazzola G; Mastella G; Piacentini I
    Eur J Epidemiol; 1996 Apr; 12(2):149-53. PubMed ID: 8817193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.